Burjeel Holdings Plc · ADX:BURJEEL
Burjeel — Q3 2025 Earnings Presentation
20 slides from Burjeel's earnings presentation, November 2025
Slide 1: Q3 & 9M 2025 Results
November 2025 Q3 & 9M 2025 Results Leading Super-Specialty Healthcare Provider in MENA
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by Burjeel Holdings PLC None of the Company or its subsidiaries or any of their affiliates or based on publicly available information and non-public advisors make any representation or warranty as to the fairness, information to assist you in making a p
Slide 3: Key Highlights
Key Highlights Leading Super-Specialty Healthcare Provider in MENA
Slide 4: Q3’25: Built on Strength — Record Performance
Q3’25: Built on Strength — Record Performance Financial Highlights Strategic Execution Impact Mid-term Focus Highlights (Q3’25) Outlook Revenue • Optimized patient flow • Outpacing population • Achieve >80% bed occupancy and capacity alignment growth with 15% YoY and sustain >12% Group Optimize Util
Slide 5: Recent Medical Developments
Recent Medical Developments Da Vinci Xi 800 Robotic Surgeries Multi-Organ Performed GCC’s First HAIP Surgery 63 Transplants Conducted a cytoreductive surgery with HIPEC for stomach cancer and the GCC’s first Hepatic Artery Infusion Pump (HAIP) implantation for liver tumors, cementing the Group’s lea
Slide 6: Differentiated Growth Strategy Driving Specialized Care Across Network
Differentiated Growth Strategy Driving Specialized Care Across Network Burjeel Holdings Today Anchor Burjeel as the MENA referral hub, attracting complex cases and exporting world-class expertise. 112 15 Healthcare assets O&M projects incl. 20 hospitals in UAE & Africa Expand community-driven, value
Slide 7: Expanding Reach, Enhancing Care: Disciplined Execution Across Growth Pipeline
Expanding Reach, Enhancing Care: Disciplined Execution Across Growth Pipeline 2025 2026 2027 Expected Impact at Maturity Advanced Oncology Acute Care Hospital, Medical Center, LLH Hospital, Center (Dubai) DIP (Dubai) Al Riyadh (Abu Dhabi) Jebel Ali (Dubai) AED 1.5 bn Revenue Medical Center, Day Surg
Slide 8: Performance Review
Performance Review Leading Super-Specialty Healthcare Provider in MENA
Slide 9: Outpacing the Market: Proven Leadership, Resilient Growth
Outpacing the Market: Proven Leadership, Resilient Growth Group Outpatient Footfall, k Group Inpatient Footfall, k % OP utilisation • Total patient footfall rose 4.6% in Q3’25 and % bed occupancy • Inpatient footfall grew 8.4% in Q3’25, reached 5.1 million in 9M’25, up 7.3%, driven by strong perform
Slide 10: Record Quarterly Financial Performance With Margins Expanding Across the Network
Record Quarterly Financial Performance With Margins Expanding Across the Network Group Revenue, AED m Group EBITDA, AED m YoY • Group Revenue reached a record high in EBITDA margin YoY • Group EBITDA grew 17.1% in Q3’25, 1,422 Q3’25, driven by patient footfall growth +7.9% +17.1% with the margin imp
Slide 11: BMC Strengthens Profitability Through Scale & Operational Excellence
BMC Strengthens Profitability Through Scale & Operational Excellence Total patients, k Revenue, AED m1 EBITDA, AED m1 % bed occupancy % EBITDA margin 65% 58% 60% 61% 16.0% 22.0% 16.1% 18.9% +19.4% +10.9% +29.8% 463 975 184 879 388 142 +13.9% +7.1% +46.8% 72 162 306 327 142 49 Q3'24 Q3'25 9M'24 9M'25
Slide 12: Trust Fertility Center: Powering UAE’s Fertility Strategy with Rapid Ramp-Up
Trust Fertility Center: Powering UAE’s Fertility Strategy with Rapid Ramp-Up Integral in Burjeel’s Women’s Health Platform 9M AED 40m Total 2,500+ Unique Patient 1,600+ IVF, FET, & IUI ~50% Clinical Pregnancy Rate 2025 Revenue Volumes Cycles Initiated (above global average) Operational Since Dec 202
Slide 13: Delivering Profitable Growth Through Scale & Cost Discipline
Delivering Profitable Growth Through Scale & Cost Discipline Group OPEX Breakdown, % of Revenue Group EBITDA Analysis, AED m % EBITDA margin 86.2% 83.4% 22.5% 79.6% 81.2% 82.1% 20.7% 77.2% +104 (31) +12 12.3% 10.4% (21) (8) 10.5% 10.9% 10.9% (9) 2.2% 3.0% 3.9% 10.3% 3.5% 320 2.0% 24.6% 3.5% 273 24.5
Slide 14: Robust Cash Flow Conversion & Net Profit Expansion
Robust Cash Flow Conversion & Net Profit Expansion Cash Flow from Operating Activities, AED m Group Net Profit Analysis, AED m % FCF conversion2 % Net profit margin 64% 42% 51% 51% 45% 37% 10.4% 12.3% 566 +104 (48) 500 (2) (2) (6) (9) 175 358 328 308 137 244 +27.5% 2021 2022 2023 2024 9M'24 9M'25 Q3
Slide 15: Well-Capitalized Balance Sheet Supporting Future Growth & Value Creation
Well-Capitalized Balance Sheet Supporting Future Growth & Value Creation AED m FY 2023 FY 2024 9M’25 Debt Maturity as of 30 September 2025 Bank balances and cash 170 238 150 416 Interest-bearing loans and borrowings 1,164 1,208 1,773 Bank overdrafts – -- -- 291 306 273 248 Bank debt1 1,164 1,208 1,7
Slide 16: Guidance
Guidance Leading Super-Specialty Healthcare Provider in MENA
Slide 17: Maintaining Growth Momentum While Building Future Margin Strength
Maintaining Growth Momentum While Building Future Margin Strength FY 2025 (Updated) Mid-term (2026-2028) • UAE: 1 Advanced Care Oncology Center, 3 Burjeel • UAE: 1 Burjeel Hospital, 1 LLH Hospital, 4 Burjeel Day Surgery Expansion Medical Centers, 6 LLH Medical Centers & Clinics, Centers, 2 Trust Fer
Slide 18: Q&A Appendix
Q&A Appendix Leading Super-Specialty Healthcare Provider in MENA
Slide 19: Group & Segment Financial Summary
Group & Segment Financial Summary Group Financial Summary Segmental Financial Summary AED millions Q3’25 Q3’24 9M’25 9M‘24 AED millions Q3’25 Q3’24 9M’25 9M‘24 Revenue 1,422 1,319 4,099 3,705 Revenue 1,422 1,319 4,099 3,705 Inventories consumed (312) (323) (985) (920) Hospitals2 1,247 1,192 3,618 3,
Slide 20: IR Contacts
IR Contacts November 2025 Sergei Levitskii Director of Investor Relations Investor Feedback Hotline sergei.levitskii@burjeelholdings.com T: +971 2 3041 111 Engaging openly with our investors and analysts is a cornerstone of our approach. We’ve partnered with Closir to make sharing your feedback quic